Major depressive disorders are a major problem—and not everyone finds relief from currently available medications. Those medications most often target brain chemicals (like serotonin), based on the belief that the depressed brain does not regulate those chemicals appropriately. But for many people, the medications might be taking the wrong approach: recent research suggests that for about 30% of people with depression, addressing inflammation in the body might be a better path.

Find out why here, on The Washington Post